Viagra Label Change Delay Shows Need For Safety Reform – Sen. Grassley

FDA's response to reports of vision loss in Viagra patients is being cited by Senate Finance Committee Chairman Charles Grassley (R-Iowa) as another reason to reform the agency's drug safety system